The world's burden of infectious diseases can be substantially reduced by more-effective use of existing interventions. Advances in case detection, diagnosis, and treatment strategies have made it possible to consider the elimination of visceral leishmaniasis in the Indian subcontinent. The priority must now be to effectively implement existing interventions at the community level by actively finding cases in endemic villages and treating them with single-dose liposomal amphotericin B at primary-health-care centres. Once the elimination target of one case per 10 000 population has been reached, combination therapies involving miltefosine and paromomycin can be introduced to ensure long-term availability of several drugs for visceral leishma...
In the Indian subcontinent, about 200 million people are at risk of developing visceral leishmaniasi...
The state of Bihar in India carries the largest share of the world's burden of antimony-resistant vi...
Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by phlebotomine sand...
The world’s burden of infectious diseases can be substantially reduced by more-eff ective use of exi...
Visceral leishmaniasis is a disease associated with poverty and poor hygiene conditions caused by th...
On the Indian subcontinent (ISC), visceral leishmaniasis (VL) is targeted for elimination as a publi...
Data on the burden of visceral leishmaniasis (VL) in Indian sub-continent are vital for elimination ...
The decade following the Regional Strategic Framework for Visceral Leishmaniasis (VL) elimination in...
Visceral leishmaniasis (VL) is one of the world s neglected diseases that take a huge toll on people...
Background: In Bihar, India, home to nearly one-half of the world's burden of visceral leishmaniasis...
Visceral leishmaniasis is common in less developed countries, with an estimated 500000 new cases eac...
Visceral leishmaniasis is common in less developed countries, with an estimated 500 000 new cases ea...
Human visceral leishmaniasis (VL), a potentially fatal disease, is most prevalent in the Indian subc...
Background The decade following the Regional Strategic Framework for Visceral Leishmaniasis (VL) eli...
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, ...
In the Indian subcontinent, about 200 million people are at risk of developing visceral leishmaniasi...
The state of Bihar in India carries the largest share of the world's burden of antimony-resistant vi...
Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by phlebotomine sand...
The world’s burden of infectious diseases can be substantially reduced by more-eff ective use of exi...
Visceral leishmaniasis is a disease associated with poverty and poor hygiene conditions caused by th...
On the Indian subcontinent (ISC), visceral leishmaniasis (VL) is targeted for elimination as a publi...
Data on the burden of visceral leishmaniasis (VL) in Indian sub-continent are vital for elimination ...
The decade following the Regional Strategic Framework for Visceral Leishmaniasis (VL) elimination in...
Visceral leishmaniasis (VL) is one of the world s neglected diseases that take a huge toll on people...
Background: In Bihar, India, home to nearly one-half of the world's burden of visceral leishmaniasis...
Visceral leishmaniasis is common in less developed countries, with an estimated 500000 new cases eac...
Visceral leishmaniasis is common in less developed countries, with an estimated 500 000 new cases ea...
Human visceral leishmaniasis (VL), a potentially fatal disease, is most prevalent in the Indian subc...
Background The decade following the Regional Strategic Framework for Visceral Leishmaniasis (VL) eli...
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, ...
In the Indian subcontinent, about 200 million people are at risk of developing visceral leishmaniasi...
The state of Bihar in India carries the largest share of the world's burden of antimony-resistant vi...
Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by phlebotomine sand...